Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 4,60€(+1,10%). Der Median liegt bei 4,60€(+1,10%).
Kaufen | 3 |
Halten | 5 |
Verkaufen | 1 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Datametrex Announces Non-Brokered Private Placement Financing
TORONTO, ON / ACCESS Newswire / June 9, 2025 / Datametrex AI Limited (the 'Company' or 'Datametrex') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it is undertaking non-brokered private placement financing of up to $3,000,000 with an offering of up to 37,500,000 Common Shares at a price of $0.08 per Common Share (the "Private Placement"), subject to TSXV acceptance. The gross proceeds of the Private Placement will be used for expansion of the Company's healthcare product offering, relocation of two healthcare clinics and general working capital.» Mehr auf accessnewswire.com
Datametrex Acquires Arbutus Health And Wellness Inc.
TORONTO, ON / ACCESS Newswire / June 6, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that further to its news release dated April 1, 2025, it has completed the acquisition of all of the issued and outstanding share capital of Arbutus Health and Wellness Inc. ("Arbutus Health"), a multidisciplinary medical clinic in Vancouver, Canada. Arbutus Health provides walk-in services, family medicine, skin laser treatments, and other specialty healthcare services in a single location.» Mehr auf accessnewswire.com
DataMetrex Signs LOI to Acquire Arbutus Health and Wellness Inc.
TORONTO, ON / ACCESS Newswire / April 1, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce the signing of a non-binding Letter of Intent ("LOI") to acquire Arbutus Health and Wellness Inc. ("Arbutus Health"), a multidisciplinary medical clinic in Vancouver Canada, on March 20, 2025. Datametrex has agreed to acquire Arbutus Health for the Purchase Price of up to $1.1 million, which will be satisfied through the issuance of an aggregate of common shares in the capital of Datametrex at $0.10 per share.» Mehr auf accessnewswire.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 32,69 Mio | - |
Bruttoeinkommen | 2,84 Mio | - |
Nettoeinkommen | −31,83 Mio | - |
EBITDA | −23,02 Mio | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 144,81 Mio€ |
Anzahl Aktien | 33,34 Mio |
52 Wochen-Hoch/Tief | 9,02€ - 1,61€ |
Dividenden | Nein |
Beta | 0,18 |
KGV (PE Ratio) | −0,45 |
KGWV (PEG Ratio) | −0,14 |
KBV (PB Ratio) | 2,28 |
KUV (PS Ratio) | 0,98 |
Unternehmensprofil
Name | Desktop Metal |
CEO | Ric Fulop |
Sitz | Burlington, ma USA |
Website | |
Industrie | Chemikalien |
Mitarbeiter | 950 |
Assets entdecken
Shareholder von Desktop Metal investieren auch in folgende Assets